Aparna MD - T2 Biosystms Chief Board
| TTOODelisted Stock | USD 0.18 0.05 21.74% |
Insider
Aparna MD is Chief Board of T2 Biosystms
| Age | 57 |
| Phone | 781 761 4646 |
| Web | https://www.t2biosystems.com |
T2 Biosystms Management Efficiency
The company has return on total asset (ROA) of (0.9046) % which means that it has lost $0.9046 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.2214) %, meaning that it created substantial loss on money invested by shareholders. T2 Biosystms' management efficiency ratios could be used to measure how well T2 Biosystms manages its routine affairs as well as how well it operates its assets and liabilities.T2 Biosystms currently holds 49.5 M in liabilities with Debt to Equity (D/E) ratio of 6.64, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. T2 Biosystms has a current ratio of 1.83, which is within standard range for the sector. Debt can assist T2 Biosystms until it has trouble settling it off, either with new capital or with free cash flow. So, T2 Biosystms' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like T2 Biosystms sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TTOO to invest in growth at high rates of return. When we think about T2 Biosystms' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| JoseCarlos GutierrezRamos | Danaher | 63 | |
| Emily Hubbard | iSpecimen | N/A | |
| Jonathan Pratt | Waters | 54 | |
| Carissa Rollins | Illumina | 54 | |
| Jianqing Bennett | Waters | 55 | |
| Alexander MD | Illumina | 47 | |
| Jennifer Honeycutt | Danaher | 54 | |
| Belinda Hyde | Waters | 53 | |
| Dan Welch | Waters | 58 | |
| BBus CA | Intelligent Bio Solutions | 60 | |
| John Ballbach | Waters | 60 | |
| Jessica Mega | Danaher | 46 | |
| Alex Arzeno | Intelligent Bio Solutions | N/A | |
| Ruby Chandy | Thermo Fisher Scientific | 58 | |
| Christopher Bouda | Danaher | N/A | |
| Pearl Huang | Waters | 62 | |
| Sandy Pound | Thermo Fisher Scientific | N/A | |
| Dawn Michelle | iSpecimen | N/A | |
| Tracy Curley | iSpecimen | 62 | |
| Xavier MS | bioAffinity Technologies, | 55 | |
| Kevin Kempskie | Waters | N/A | |
Management Performance
| Return On Equity | -6.22 | ||||
| Return On Asset | -0.9 |
T2 Biosystms Leadership Team
Elected by the shareholders, the T2 Biosystms' board of directors comprises two types of representatives: T2 Biosystms inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TTOO. The board's role is to monitor T2 Biosystms' management team and ensure that shareholders' interests are well served. T2 Biosystms' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, T2 Biosystms' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Roger Smith, Senior Development | ||
| Aparna MD, Chief Board | ||
| Kelley Morgan, Chief Officer | ||
| BSc III, CEO President | ||
| Michael Esq, Sr Counsel | ||
| Brett Giffin, Chief Officer | ||
| Alec Barclay, Senior Vice President - Operations | ||
| John CPA, Chief Officer |
TTOO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is T2 Biosystms a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.22 | ||||
| Return On Asset | -0.9 | ||||
| Operating Margin | (4.91) % | ||||
| Current Valuation | 21.91 M | ||||
| Shares Outstanding | 21.04 M | ||||
| Shares Owned By Insiders | 10.17 % | ||||
| Shares Owned By Institutions | 73.51 % | ||||
| Number Of Shares Shorted | 826.91 K | ||||
| Price To Earning | (2.04) X | ||||
| Price To Book | 14.50 X |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in TTOO Pink Sheet
If you are still planning to invest in T2 Biosystms check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystms' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |